PORTAL HYPERTENSION side effect
What is PORTAL HYPERTENSION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PORTAL HYPERTENSION and Recently Reported Side Effects
PORTAL HYPERTENSION and 15 most Active Side Effect polls
PORTAL HYPERTENSION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with PORTAL HYPERTENSION
AMOXICILLIN APROVEL APTIVUS BEVACIZUMAB BYETTA CLOZARIL DACOGEN DESFERAL ENBREL FARESTON GEMCITABINE KALETRA ORFADIN REMICADE RITONAVIR VIRAMUNE XELODAAmoxicillin Side Effects Report #5640603-X
Consumer or non-health professional from UNITED KINGDOM reported AMOXICILLIN problem on Feb 21, 2008. Male patient, 40 years of age, was diagnosed with sepsis, schizophrenia and was treated with AMOXICILLIN. After drug was administered, patient experienced the following problems/side effects: portal hypertension, portal vein thrombosis, splenomegaly, . AMOXICILLIN dosage: 500 MG, TID. During the same period patient was treated with FERROUS FUMARATE, LACTULOSE, METRONIDAZOLE, CLOZAPINE. Patient was hospitalized. Patient recovered.
Amoxicillin Side Effects Report #5642329-5
AMOXICILLIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 21, 2008. Male patient, 40 years of age, was diagnosed with sepsis, schizophrenia and was treated with AMOXICILLIN. After drug was administered, patient experienced the following problems/side effects: portal hypertension, portal vein thrombosis, splenomegaly, . AMOXICILLIN dosage: 500 MG, TID. During the same period patient was treated with FERROUS FUMARATE, LACTULOSE, METRONIDAZOLE, CLOZAPINE. Patient was hospitalized. Patient recovered.
Ritonavir Side Effects Report #5780528-2
Consumer or non-health professional from BRAZIL reported RITONAVIR SOFT GELATIN CAPSULES problem on June 17, 2008. Female patient, weighting 116.2 lb, was diagnosed with hiv infection and was treated with RITONAVIR SOFT GELATIN CAPSULES. After drug was administered, patient experienced the following problems/side effects: portal hypertension, upper gastrointestinal haemorrhage, . RITONAVIR SOFT GELATIN CAPSULES dosage: unknown. During the same period patient was treated with TMC. Patient was hospitalized. Patient recovered.
Desferal Side Effects Report #5726647-8
DESFERAL problem was reported by a Physician from ITALY on Apr 24, 2008. Female patient, 38 years of age, weighting 125.7 lb, was diagnosed with haemosiderosis, amenorrhoea and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: portal hypertension, portal vein thrombosis, varices oesophageal, . DESFERAL dosage: 10 MG/KG, QD. During the same period patient was treated with SANDRENA, FARLUTAL. Patient recovered.
Desferal Side Effects Report #5710933-1
Physician from ITALY reported DESFERAL problem on Apr 10, 2008. Female patient, 38 years of age, weighting 125.7 lb, was diagnosed with haemosiderosis and was treated with DESFERAL. After drug was administered, patient experienced the following problems/side effects: portal hypertension, portal vein thrombosis, varices oesophageal, . DESFERAL dosage: 10 MG/KG, QD. Patient recovered.
Fareston Side Effects Report #5337501-8
FARESTON problem was reported by a Consumer or non-health professional from JAPAN on May 17, 2007. Female patient, 72 years of age, was diagnosed with breast cancer and was treated with FARESTON. After drug was administered, patient experienced the following problems/side effects: portal hypertension, portal vein occlusion, portal vein stenosis, varices oesophageal, . FARESTON dosage: unknown. During the same period patient was treated with ASPIRIN, MEDROXYPROGESTERONE ACETATE. Patient recovered.
Bevacizumab Side Effects Report #5673798-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 11, 2008. Female patient, 81 years of age, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: ascites, portal hypertension, . BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with PEGFILGRASTIM, FOLINIC ACID, FLUOROURACIL, OXALIPLATIN, CETUXIMAB. Patient recovered.
Enbrel Side Effects Report #5678876-X
ENBREL problem was reported by a Physician from CANADA on Mar 13, 2008. Male patient, 52 years of age, was diagnosed with arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: hepatic failure, portal hypertension, splenomegaly, . ENBREL dosage: unknown. Patient recovered.
Byetta Side Effects Report #5645019-8
Physician from UNITED STATES reported BYETTA problem on Feb 21, 2008. Male patient was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, portal hypertension, varices oesophageal, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, ACTOS. Patient recovered.
Clozaril Side Effects Report #5477936-6
CLOZARIL problem was reported by a Physician from UNITED STATES on Sept 27, 2007. Male patient, 47 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: hepatitis, portal hypertension, . CLOZARIL dosage: unknown. Patient recovered.
Dacogen Side Effects Report #5489203-5
Physician from UNITED STATES reported DACOGEN problem on Oct 01, 2007. Female patient was diagnosed with myelodysplastic syndrome and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, portal hypertension, . DACOGEN dosage: 20 MG/M2, INTRAVENOUS. Patient died.
Aprovel Side Effects Report #5412483-9
APROVEL problem was reported by a Health Professional from FRANCE on Aug 08, 2007. Female patient, 43 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with APROVEL. After drug was administered, patient experienced the following problems/side effects: cholangitis, portal hypertension, . APROVEL dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR, VIRAMUNE. Patient recovered.
Viramune Side Effects Report #5415885-X
Physician from FRANCE reported VIRAMUNE problem on Aug 08, 2007. Female patient, 43 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cholangitis, portal hypertension, . VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, IRBESARTAN, EPIVIR. Patient recovered.
Byetta Side Effects Report #5728062-X
BYETTA problem was reported by a Physician from UNITED STATES on Apr 21, 2008. Male patient was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: hepatic steatosis, portal hypertension, varices oesophageal, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, ACTOS. Patient recovered.
Xeloda Side Effects Report #5743715-5
Physician from UNITED STATES reported XELODA problem on May 08, 2008. Male patient, 59 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, portal hypertension, venous thrombosis, . XELODA dosage: unknown. During the same period patient was treated with GEMCITABINE, FLOMAX, PROTONIX, ALDACTONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5702347-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Apr 03, 2008. Female patient, 81 years of age, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: ascites, portal hypertension, . BEVACIZUMAB dosage: 5 MG/KG, Q2W. During the same period patient was treated with PEGFILGRASTIM, FOLINIC ACID, FLUOROURACIL, OXALIPLATIN, CETUXIMAB. Patient recovered.
Gemcitabine Side Effects Report #5706551-1
Physician from UNITED STATES reported GEMCITABINE problem on Apr 02, 2008. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity, portal hypertension, . GEMCITABINE dosage: 1000 MG/M2, OTHER. During the same period patient was treated with OXALIPLATIN. Patient recovered.
Kaletra Side Effects Report #5475253-1
KALETRA problem was reported by a Physician from FRANCE on Sept 25, 2007. Female patient, 52 years of age, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: asthenia, hepatic fibrosis, portal hypertension, . KALETRA dosage: unknown. During the same period patient was treated with DIDANOSINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.
Aptivus Side Effects Report #5381049-1
Physician from reported APTIVUS problem on July 06, 2007. Male patient, weighting 187.4 lb, was diagnosed with hiv infection and was treated with APTIVUS. After drug was administered, patient experienced the following problems/side effects: bicytopenia, hepatitis cholestatic, portal hypertension, splenomegaly, . APTIVUS dosage: 500 MG TIPRANAVIR + 200 MG RITONAVIR. During the same period patient was treated with TENOFOVIR, STAVUDINE, FUZEON. Patient was hospitalized. Patient recovered.
Aptivus Side Effects Report #5392555-8
APTIVUS problem was reported by a Physician from on July 18, 2007. Male patient, weighting 187.4 lb, was diagnosed with hiv infection and was treated with APTIVUS. After drug was administered, patient experienced the following problems/side effects: bicytopenia, hepatitis cholestatic, portal hypertension, splenomegaly, . APTIVUS dosage: 500 MG TIPRANAVIR + 200 MG RITONAVIR. During the same period patient was treated with TENOFOVIR, STAVUDINE, FUZEON. Patient was hospitalized. Patient recovered.
Aptivus Side Effects Report #5381049-1
Physician from reported APTIVUS problem on July 06, 2007. Male patient, weighting 187.4 lb, was diagnosed with hiv infection and was treated with APTIVUS. After drug was administered, patient experienced the following problems/side effects: bicytopenia, hepatitis cholestatic, portal hypertension, splenomegaly, . APTIVUS dosage: 500 MG TIPRANAVIR + 200 MG RITONAVIR. During the same period patient was treated with TENOFOVIR, STAVUDINE, FUZEON. Patient was hospitalized. Patient recovered.
Aptivus Side Effects Report #5392555-8
APTIVUS problem was reported by a Physician from on July 18, 2007. Male patient, weighting 187.4 lb, was diagnosed with hiv infection and was treated with APTIVUS. After drug was administered, patient experienced the following problems/side effects: bicytopenia, hepatitis cholestatic, portal hypertension, splenomegaly, . APTIVUS dosage: 500 MG TIPRANAVIR + 200 MG RITONAVIR. During the same period patient was treated with TENOFOVIR, STAVUDINE, FUZEON. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5365599-X
Health Professional from CANADA reported REMICADE problem on June 11, 2007. Female patient, weighting 132.3 lb, was diagnosed with psoriatic arthropathy, psoriasis, latent tuberculosis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, pancytopenia, portal hypertension, splenomegaly, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
Orfadin Side Effects Report #5266640-5
ORFADIN problem was reported by a Physician from ISRAEL on Feb 16, 2007. Male patient, child 8 years of age, weighting 49.00 lb, was diagnosed with tyrosinaemia and was treated with ORFADIN. After drug was administered, patient experienced the following problems/side effects: cyanosis, hypotonia, portal hypertension, scrotal swelling, varices oesophageal, . ORFADIN dosage: 20 MILLIGRAM A DAY; ORAL. Patient was hospitalized. Patient died on 03/17/2006.